Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,502.86
+266.01(+0.53%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Takeda Pharmaceutical Company Limited (TKD.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

24.67

+0.06

(+0.24%)

At close: 09:49PM CEST

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	39.41B
Enterprise value	65.87B
Trailing P/E	36.53
Forward P/E	23.15
PEG ratio (5-yr expected)	3.25
Price/sales (ttm)	1.56
Price/book (mrq)	0.96
Enterprise value/revenue	0.02
Enterprise value/EBITDA	0.06

Trading information

Stock price history

Beta (5Y monthly)	0.54
52-week change ³	-19.22%
S&P500 52-week change ³	22.38%
52-week high ³	30.99
52-week low ³	24.26
50-day moving average ³	25.78
200-day moving average ³	26.73

Share statistics

Avg vol (3-month) ³	198
Avg vol (10-day) ³	178
Shares outstanding ⁵	1.57B
Implied shares outstanding ⁶	1.6B
Float ⁸	1.55B
% held by insiders ¹	0.03%
% held by institutions ¹	44.81%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	1.15
Forward annual dividend yield ⁴	4.67%
Trailing annual dividend rate ³	184.00
Trailing annual dividend yield ³	747.66%
5-year average dividend yield ⁴	4.73
Payout ratio ⁴	163.61%
Dividend date ³	N/A
Ex-dividend date ⁴	28 Mar 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends	31 Mar 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	4.28%
Operating margin (ttm)	9.44%

Management effectiveness

Return on assets (ttm)	2.61%
Return on equity (ttm)	2.76%

Income statement

Revenue (ttm)	4.17T
Revenue per share (ttm)	2,670.94
Quarterly revenue growth (yoy)	1.30%
Gross profit (ttm)	N/A
EBITDA	1.21T
Net income avi to common (ttm)	178.22B
Diluted EPS (ttm)	0.68
Quarterly earnings growth (yoy)	-11.30%

Balance sheet

Total cash (mrq)	288.36B
Total cash per share (mrq)	183.79
Total debt (mrq)	5.21T
Total debt/equity (mrq)	77.21%
Current ratio (mrq)	1.06
Book value per share (mrq)	4,297.21

Cash flow statement

Operating cash flow (ttm)	731.45B
Levered free cash flow (ttm)	-9.88B